“Increase in R&D Spending on Biopharmaceutical Projects”
The increase in R&D spending on biopharmaceutical projects is driving the growth of the global cell culture media market. Biopharmaceutical companies are investing heavily in R&D to develop new treatments and therapies, which requires the use of high-quality cell culture media to support the growth and testing of biological products. As a result, the demand for cell culture media is increasing as biopharmaceutical companies require advanced cell culture media to support their R&D activities. For Instance, In July 2024, according to an article published in The Economic Times, the revised estimate of allocation to the Ministry of Health and Family Welfare showed an increase of approx. 1.73% over the revised estimate of 2022-23. This is done in the aim of developing high-value novel drugs, bio-pharmaceuticals and biosimilar that require considerable research and development efforts. The development of new biological products, such as monoclonal antibodies, vaccines, and gene therapies, requires the use of advanced cell culture media. These products require specific growth conditions, such as temperature, pH, and nutrient levels, which can be challenging to replicate in vitro. Advanced cell culture media that can support the growth and testing of these biological products is driving demand for specialized cell culture media.
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE CELL CULTURE MEDIA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 EUROPE CELL CULTURE MEDIA MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION
6.2.2 HIGH COST OF PRODUCTION
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATION AND PARTNERSHIPS
6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES
6.3.3 INNOVATIONS IN 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 COMPLEXITY OF MEDIA FORMULATION
6.4.2 INTENSE MARKET COMPETITION
7 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE
7.1 OVERVIEW
7.2 CHEMICALLY DEFINED MEDIA
7.3 CLASSICAL MEDIA
7.4 SERUM-FREE MEDIA
7.4.1 CHO MEDIA
7.4.2 HEK 293 MEDIA
7.4.3 CAR T-CELL MEDIA
7.4.4 VERO CELL MEDIA
7.4.5 BHK MEDIA
7.4.6 INSECT CELL MEDIA
7.4.7 SERUM-FREE CELL MEDIA
7.4.8 OTHER SERUM-FREE MEDIA
7.5 SPECIALTY MEDIA
7.6 STEM CELL MEDIA
7.6.1 MESENCHYMAL STEM CELLS (MSCS)
7.6.2 NEURAL STEM CELLS (NSCS)
7.6.3 EMBRYONIC STEM CELLS (ESCS)
7.6.4 BONE MARROW
7.6.5 OTHERS
7.7 LYSOGENY BROTH (LB)
7.8 CUSTOM MEDIA FORMULATION
7.9 OTHERS
8 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODIES
8.2.2 VACCINES PRODUCTION
8.2.3 OTHERS
8.3 DRUG SCREENING & DEVELOPMENT
8.4 DIAGNOSTICS
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING
8.5.1 STEM CELL AND GENE THERAPY
8.5.2 OTHERS
8.6 OTHERS
9 EUROPE CELL CULTURE MEDIA MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOPHARMACEUTICAL COMPANIES
9.3 BIOTECHNOLOGY ORGANIZATIONS
9.4 ACADEMIC AND RESEARCH LABORATORIES
9.5 HOSPITALS
9.6 DIAGNOSTIC CENTERS
9.7 CELL BANKS
9.8 FORENSIC LABORATORIES
9.9 OTHERS
10 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 THIRD PARTY DISTRIBUTION
10.4 RETAILS SALES
11 EUROPE CELL CULTURE MEDIA MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 U.K.
11.1.3 FRANCE
11.1.4 NETHERLANDS
11.1.5 SPAIN
11.1.6 SWITZERLAND
11.1.7 BELGIUM
11.1.8 ITALY
11.1.9 RUSSIA
11.1.10 TURKEY
11.1.11 REST OF EUROPE
12 EUROPE MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 DANAHER CORPORATION (CYTIVA)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 LONZA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 CORNING INCORPORATED
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT UPDATES
14.7 AJINOMOTO CO., INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AKRON BIOTECH
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT UPDATES
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CAISSON LABS INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT UPDATES
14.12 CELL APPLICATION, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT UPDATES
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 FUJIFILM HOLDINGS CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT UPDATES
14.15 HIMEDIA LABORATORIES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT UPDATES
14.16 KOH JIN-BIO CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT UPDATES
14.17 PAN-BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT UPDATES
14.18 PROMOCELL GMBH
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT UPDATES
14.19 SERA-SCANDIA A/S
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STEMCELL TECHNOLOGIES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TAKARA BIO INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 GMP REQUIREMENTS
TABLE 2 SCOPE OF THE CURRENT DOCUMENT
TABLE 3 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 6 EUROPE CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 EUROPE CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 EUROPE SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 EUROPE LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 EUROPE CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 17 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 EUROPE DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 EUROPE DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 25 EUROPE BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 EUROPE BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 EUROPE ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 EUROPE HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 EUROPE DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 EUROPE CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 EUROPE FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 34 EUROPE DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 EUROPE THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 EUROPE RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 38 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 39 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 42 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 43 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 45 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 53 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 54 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 57 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 58 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 59 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 61 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 62 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 63 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 66 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 69 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 74 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 77 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 78 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 82 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 83 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 85 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 86 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 90 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 93 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 94 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 96 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 97 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 98 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 100 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 101 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 102 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 106 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 109 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 110 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 114 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 115 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 117 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 118 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 119 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 122 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 125 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 126 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
List of Figure
FIGURE 1 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 2 EUROPE CELL CULTURE MEDIA MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CELL CULTURE MEDIA MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CELL CULTURE MEDIA MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE EUROPE CELL CULTURE MEDIA MARKET FROM 2024 TO 2031
FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL CULTURE MEDIA MARKET IN 2024 AND 2031
FIGURE 15 DROC ANALYSIS
FIGURE 16 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, 2023
FIGURE 17 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 18 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023
FIGURE 21 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 22 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 23 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, 2023
FIGURE 25 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 26 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)
FIGURE 27 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 29 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 30 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 31 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 EUROPE CELL CULTURE MEDIA MARKET: SNAPSHOT
FIGURE 33 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
